Работы, на которые ссылается эта работа

Работ: 53

Работа: Design of competitive inhibitory peptides for 3-hydroxy-3-Methylglutaryl coenzyme A reductase

Isolation and Identification of Peptides from Soy 11S-Globulin with Hypocholesterolemic Activity
Valeriy V. Pak, Minseon Koo, T. D. Kasymova +1
СтатьяProtein Hydrolysis and Bioactive PeptidesChemistry of Natural Compounds2005Цитирований: 14
ABI
Statin inhibition of HMG-CoA reductase: a 3-dimensional view
Eva S. Istvan
Обзорная статья2003Цитирований: 13
ABI
Structure—Activity Relationships of the Peptide Ile-Ala-Val-Pro and Its Derivatives Revealed Using the Semi-Empirical AM1 Method
Valeriy V. Pak, Minseon Koo, N. Lee +2
Статья2005Цитирований: 12
ABI
Peptide design of a competitive inhibitor for HMG‐CoA reductase based on statin structure
Valeriy V. Pak, Sung Hee Kim, Minseon Koo +3
СтатьяComputational Drug Discovery MethodsBiopolymers2006Цитирований: 10
ABI
Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG‐CoA reductase
Valeriy V. Pak, Minseon Koo, Min Jung Kim +3
СтатьяRNA and protein synthesis mechanismsJournal of Molecular Recognition2008Цитирований: 8
ABI
Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone
Valeriy V. Pak, Minseon Koo, Min Jung Kim +2
СтатьяComputational Drug Discovery MethodsBioorganic & Medicinal Chemistry2007Цитирований: 6
ABI
Structures of the Peptide Leu-Pro-Tyr-Pro and Its Derivatives and the Nicotinamide Part of NADPH by a Semi-Empirical PM3 Method
Valeriy V. Pak, Meng-Yu Ku, Na Li +3
СтатьяEnzyme Structure and FunctionChemistry of Natural Compounds2005Цитирований: 5
ABI
Peptide fragmentation as an approach in modeling of an active peptide and designing a competitive inhibitory peptide for HMG-CoA reductase
Valeriy V. Pak, Minseon Koo, Dae Young Kwon +2
СтатьяComputational Drug Discovery MethodsBioorganic & Medicinal Chemistry2010Цитирований: 5
ABI
Crystal structure of the catalytic portion of human HMG‐CoA reductase: insights into regulation of activity and catalysis
Eva S. Istvan, Maya Palnitkar, Susan K. Buchanan +1
Статья2000Цитирований: 5
ABI
Syntheses of some α-cyclic tripeptides as potential inhibitors for HMG-CoA Reductase
Subrata Chakraborty, Shih‐Hung Lin, David Shiuan +1
Статья2015Цитирований: 5
ABI
Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase
Valeriy V. Pak, Minseon Koo, Dae Young Kwon +1
СтатьяComputational Drug Discovery MethodsAmino Acids2012Цитирований: 4
ABI
Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
Valeriy V. Pak, Dae Yong Kwon, Olim K. Khojimatov +2
СтатьяComputational Drug Discovery MethodsInternational Journal of Peptide Research and Therapeutics2021Цитирований: 4
ABI
In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide
Mariana Silva, Caio Souza, Biane Oliveira Philadelpho +7
Статья2018Цитирований: 4
ABI
IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach
Mariana Silva, Biane Oliveira Philadelpho, Johnnie Elton Machado dos Santos +9
Статья2021Цитирований: 4
ABI
Risk of incident diabetes among patients treated with statins: population based study
A. A. Carter, Tara Gomes, Ximena Camacho +3
Статья2013Цитирований: 3
ABI
Peptides from cowpea present antioxidant activity, inhibit cholesterol synthesis and its solubilisation into micelles
Marcelo Rodrigues Marques, Rosana Aparecida Manólio Soares Freitas, Amanda Caroline Corrêa Carlos +3
Статья2014Цитирований: 3
ABI
IAVPGEVA, IAVPTGVA, and LPYP, three peptides from soy glycinin, modulate cholesterol metabolism in HepG2 cells through the activation of the LDLR-SREBP2 pathway
Carmen Lammi, Chiara Zanoni, Anna Arnoldi
Статья2015Цитирований: 3
ABI
Statin use and risk of diabetes mellitus in postmenopausal women
Niki Katsiki, Maciej Banach
Статья2012Цитирований: 3
ABI
Lupin protein exerts cholesterol-lowering effects targeting PCSK9: From clinical evidences to elucidation of the in vitro molecular mechanism using HepG2 cells
Carmen Lammi, Chiara Zanoni, Laura Calabresi +1
Статья2016Цитирований: 3
ABI
Hypocholesterolemic effect of sericin-derived oligopeptides in high-cholesterol fed rats
Phakhamon Lapphanichayakool, Manote Sutheerawattananonda, Nanteetip Limpeanchob
Статья2016Цитирований: 3
ABI
Structure–activity studies of protease activating, lipase inhibiting, bile acid binding and cholesterol-lowering effects of pre-screened cumin seed bioactive peptides
Hwee-Leng Siow, Sy Bing Choi, Chee‐Yuen Gan
Статья2016Цитирований: 3
ABI
The Global Burden of Cardiovascular Diseases and Risk Factors
George A. Mensah, Gregory A. Roth, Valentı́n Fuster
Редакционная статья2019Цитирований: 3
ABI
Design of competitive inhibitory peptides for HMG-CoA reductase and modeling structural preference for short linear peptides
Valeriy V. Pak, Olim K. Khojimatov, Aleksandr V. Pak +1
СтатьяComputational Drug Discovery MethodsJournal of Molecular Structure2022Цитирований: 3
ABI
Structure-function properties of hypolipidemic peptides
Satoshi Nagaoka
Обзорная статья2018Цитирований: 2
ABI
Behavior of three hypocholesterolemic peptides from soy protein in an intestinal model based on differentiated Caco-2 cell
Gilda Aiello, Simonetta Ferruzza, Giulia Ranaldi +4
Статья2018Цитирований: 2
ABI